Jessica Moore Appointed Group Chief Financial Officer, Johnson & Johnson, Innovative Medicine Johnson & Johnson (NYSE: JNJ) (the “Company”) today announced the appointment of Darren Snellgrove ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback